Clinical Trial Update: Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating LP002 in combination with chemotherapy for extensive-stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• LP002

Snippet

Sponsor: Taizhou HoudeAoke Biomedical Co., Ltd. | Conditions: Small-cell Lung Cancer | Phase 2 | Status: UNKNOWN